CHARACTERISTICS AND OUTCOMES FOR STATIN-INTOLERANT WOMEN RECEIVING BEMPEDOIC ACID IN THE CLEAR OUTCOMES TRIAL

被引：0
|
作者：
Cho, Leslie [1 ]
Plutzky, Jorge [1 ]
Brennan, Danielle [1 ]
Louie, Michael [1 ]
Lei, Lei [1 ]
Robinson, Paula [1 ]
Powell, Heather [1 ]
Nicholls, Stephen J. [1 ]
Lincoff, A. Michael [1 ]
Nissen, Steven E. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1213-224
引用
收藏
页码：1751 / 1751
页数：1
相关论文
共 50 条
  • [41] Outcomes in Statin Intolerant Patients: The Cleveland Clinic Experience
    Mampuya, Warner
    Cho, Leslie
    Frid, David
    Huang, Julie
    Rocco, Michael
    Brennan, Danielle M.
    Hazen, Stanley L.
    CIRCULATION, 2011, 124 (21)
  • [42] Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex
    Cho, Leslie
    Plutzky, Jorge
    Brennan, Danielle
    Louie, Michael J.
    Lei, Lei
    Robinson, Paula
    Powell, Heather A.
    Nicholls, Stephen J.
    Lincoff, A. Michael
    Nissen, Steven E.
    CIRCULATION, 2024, 149 (22) : 1775 - 1777
  • [43] A Systematic Review and Meta-Analysis on the Role of Bempedoic Acid in Cardiovascular Outcomes for Patients With Statin Intolerance
    Serour, Mohamed H.
    Egaimi, Musab
    Khan, Zahid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [44] Effect of bempedoic acid on mortality and cardiovascular events in primary and secondary prevention: A post-hoc analysis of the CLEAR-outcomes trial
    Sayed, Ahmed
    Brophy, James M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 406
  • [45] Bempedoic Acid: A Contemporary Review of Its Pharmacology, Efficacy, and Safety Profile, Including Recent Data from the CLEAR Outcomes Clinical Trial
    Park, Jong Kun
    Balarbar, Noah
    Agarwala, Anandita
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (9) : 969 - 978
  • [46] Bempedoic Acid: A Contemporary Review of Its Pharmacology, Efficacy, and Safety Profile, Including Recent Data from the CLEAR Outcomes Clinical Trial
    Jong Kun Park
    Noah Balarbar
    Anandita Agarwala
    Current Cardiology Reports, 2023, 25 : 969 - 978
  • [47] SIMULATION OF EZETIMIBE AND BEMPEDOIC ACID EFFECT ON LDL-C GOAL ATTAINMENT IN STATIN-INTOLERANT PATIENTS ACROSS EUROPE: THE 1-YEAR FOLLOW-UP SANTORINI OBSERVATIONAL STUDY
    Farnier, Michel
    Ray, Kausik
    Catapano, Alberico
    Allouche, Radhouan
    Becker, Christian
    Diamand, Francoise
    Ferrieres, Jean
    ATHEROSCLEROSIS, 2024, 395
  • [48] Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial (vol 9, pg 245, 2024)
    Nicholls, S. J.
    Nelson, A. J.
    Lincoff, A. M.
    JAMA CARDIOLOGY, 2024, 9 (07) : 674 - 674
  • [49] Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial
    Koba, Shinji
    Inoue, Ikuo
    Cyrille, Marcoli
    Lu, Chen
    Inomata, Hyoe
    Shimauchi, Junichiro
    Kajinami, Kouji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2020, 27 (05) : 471 - 484
  • [50] Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial
    Nissen, Steven E.
    Dent-Acosta, Ricardo E.
    Rosenson, Robert S.
    Stroes, Erik
    Sattar, Naveed
    Preiss, David
    Mancini, John
    Ballantyne, Christie M.
    Catapano, Alberico
    Gouni-Berthold, Ioanna
    Stein, Evan A.
    Xue, Allen
    Wasserman, Scott M.
    Scott, Rob
    Thompson, Paul D.
    CLINICAL CARDIOLOGY, 2016, 39 (03) : 137 - 144
12345